摘要
贫铀(DU)一般被认为是一种新兴的污染物,在伊拉克九十年代初,在军事行动“沙漠风暴”期间,它首次被广泛地引入环境。 DU被假设为代表暴露的士兵以及战区污染地区居民的危险因素。在这篇综述中,对环境释放的DU对人类健康可能产生的后果进行了批判性分析。第一部分,总结了杜的化学性质及其主要的军民用途。本文第二部分主要对DU的吸收,血液转运,组织分布和排泄机制进行简要分析。以下部分涉及与过度暴露于DU有关的病理状况。发育和出生缺陷,波斯湾综合征和与DU有关的肾脏疾病都是第三部分讨论的论点。最后,关于DU暴露和癌症暴发的数据将得到批判性分析,包括白血病/淋巴瘤,肺癌,子宫颈癌,乳腺癌,膀胱癌和睾丸癌。作者的目的是为了讨论DU及其对人类健康和疾病的影响.
关键词: 铀的贫化,铀的化学性质,铀的新陈代谢,铀毒性,波斯湾综合症,沙漠风暴。
Current Medicinal Chemistry
Title:Depleted Uranium and Human Health
Volume: 25 Issue: 1
关键词: 铀的贫化,铀的化学性质,铀的新陈代谢,铀毒性,波斯湾综合症,沙漠风暴。
摘要: Depleted uranium (DU) is generally considered an emerging pollutant, first extensively introduced into environment in the early nineties in Iraq, during the military operation called “Desert Storm”. DU has been hypothesized to represent a hazardous element both for soldiers exposed as well as for the inhabitants of the polluted areas in the war zones. In this review, the possible consequences on human health of DU released in the environment are critically analyzed. In the first part, the chemical properties of DU and the principal civil and military uses are summarized. A concise analysis of the mechanisms underlying absorption, blood transport, tissue distribution and excretion of DU in the human body is the subject of the second part of this article. The following sections deal with pathological condition putatively associated with overexposure to DU. Developmental and birth defects, the Persian Gulf syndrome, and kidney diseases that have been associated to DU are the arguments treated in the third section. Finally, data regarding DU exposure and cancer insurgence will be critically analyzed, including leukemia/lymphoma, lung cancer, uterine cervix cancer, breast cancer, bladder cancer and testicular cancer. The aim of the authors is to give a contribution to the debate on DU and its effects on human health and disease.
Export Options
About this article
Cite this article as:
Depleted Uranium and Human Health, Current Medicinal Chemistry 2018; 25 (1) . https://dx.doi.org/10.2174/0929867324666170426102343
DOI https://dx.doi.org/10.2174/0929867324666170426102343 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Secreted Heat Shock Protein-90α: A More Effective and Safer Target for Anti-Cancer Drugs?
Current Signal Transduction Therapy Active Tumor Targeting of Nanomaterials Using Folic Acid, Transferrin and Integrin Receptors
Current Drug Discovery Technologies Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment
Current Cancer Drug Targets Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
Recent Patents on Anti-Cancer Drug Discovery Synthesis and Inhibitory Effects of Some Novel 1,3-diarylprop-2-en-1-one Analogues in Foxp3 Expression: A Novel Class of Anti-cancer Candidates
Medicinal Chemistry The Use of the Inhibitory Receptors for Modulating the Immune Responses
Current Pharmaceutical Design Pharmacological Perspectives of Wasp Venom
Protein & Peptide Letters Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome
Current Pharmacogenomics Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives
Current Topics in Medicinal Chemistry Vitamin E and All-Cause Mortality: A Meta-Analysis
Current Aging Science Vinorelbine in Cancer Therapy
Current Drug Targets Inhibitory Potential of Dietary Nutraceuticals on Cellular PI3K/Akt Signaling: Implications in Cancer Prevention and Therapy
Current Topics in Medicinal Chemistry Gene Delivery for Cancer Therapy
Current Drug Delivery Neuregulin Signaling in Pieces-Evolution of the Gene Family
Current Pharmaceutical Design Peeking into the Black Box: How Cytokine Antibody Arrays Shed Light on Molecular Mechanisms of Breast Cancer Development and its Treatment
Current Proteomics The Role of Chronic Periodontitis in Prevention and Treatment of Head and Neck Cancers
Current Cancer Therapy Reviews Metal Toxicity and Speciation: A Review
Current Medicinal Chemistry ETS Proteins and MMPs: Partners in Invasion and Metastasis
Current Drug Targets Collateral Damage Control in Cancer Therapy: Defining the Stem Identity in Gliomas
Current Pharmaceutical Design Near-infrared Light Responsive Upconversion Nanoparticles for Imaging, Drug Delivery and Therapy of Cancers
Current Nanoscience